Pangaea Zimbabwe kicks off CATALYST Study Stage 2 today at the SHAZ! Hub in Chitungwiza, introducing Cabotegravir long acting injectable. This marks a significant step in the implementation of HIV prevention choice.

#CATALYSTstudy #CAB -LA #CHOICE #MOSAIC

The ED of DARE Organization 🇹🇿 presenting progress in #HIV prevention advocacy in Tanzania, in partnership with Frontline AIDS. Focus is ensuring the development of the #HIV prevention road map, which would also outline the implementation of CAB-LA #UnitedforPrevention

Final reminder! 🚨 Join AVAC and TogetHER for Health tomorrow, April 25 at 8AM ET to discuss the importance of #HPV vaccinations among #PLHIV . More info, and registration here: avac.org/event/the-impo…

Just in! 💥 Last week, over 1,000 advocates, researchers, policy experts, and service providers attended NMAC's Biomedical HIV Prevention Summit. AVAC's own Kenyon Farrow provides an overview of the meeting including the PrEP In Black America pre-summit: avac.org/blog/biomedica…

AVACers celebrating our ED, Mitchell Warren’s 20th anniversary of advocacy, impact and commitment to HIV prevention and global health equity!

Check out his recent interview, pharmaboardroom.com/interviews/mit…, and the latest NYT piece on the future of PrEP, nytimes.com/2024/04/17/hea…

Are you ready🥳🥳🥳 join us tomorrow, Thursday 25th April at 4pm EAT as our Team lead Shakirah the Truth Teller speaks in the April Edition of Under The Tree with Under The Tree WACI Health AfNHi APHA
In a conversation themed ; The Vital Role of Young People in advocacy.

Cheers to unforgettable nights of celebration and the thoughtful gifts that make them even more special!

A huge thank you to Dr Tlaleng Mofokeng and Nono Eland for these incredible books.
They're not just reads; they're empowering guides every girl should have. Grateful beyond words!

Sidaction & Aidsfonds announce a joint call for proposals on #HIV cure
Are you an #HIV researcher from France, The Netherlands or #Africa & interested in this call?
SUBMIT LOI BY: 16 JUNE 2024

MORE HERE: bit.ly/4b3WEE7

#EmpoweringAfricanScience

The path to ending #AIDS is clear. We just need to forge strong political commitment to  #PutPeopleFirst  and invest in evidence-based programming.

Exactly 3 months to go till #AIDS 2024 ⏳ Join thousands of stakeholders around the world in telling your stories #PutPeopleFirst ⤵️

Prof. Kamya shares how prevention options (i.e. prevention products) increased as well as other aspects of choice (i.e. refills, testing). From Prof. Moses R. Kamya 🔊 “Our intervention drastically improved prevention coverage under significant increases across all subgroups.”

„The backlash on LGBTIQ*-rights is a backlash on the fight against HIV“, says Peter Sands during todays The Global Fund Board meeting #Uganda GlobalFundAdvocates #RepealAHA23 Let's Walk Uganda (LWU) AIDS Action Europe Frontline AIDS

As we kick-off today's webinar disccusing results from the SEARCH study, Prof. Moses R. Kamya shares a breakdown of the SEARCH consortium including its mission, founding directors, stakeholders, and sponsored institutions. Check out more here!

Reminder! ⏰ Today at 10AM ET, AVAC and the SEARCH team are discussing results from the SEARCH study, and the role choice plays in #HIV prevention. Save your seat if you haven't already by registering here ➡️ avac.org/event/search-d…

'The array of biomedical options that have been created is astounding – we now have an injectable, a vaginal ring, and an oral pill – but these options need to be actual choices for people' says Mitchell Warren AVAC pharmaboardroom.com/interviews/mit…

Excellent paper by Jeanne Marrazzo, Connie Celum, & colleagues summarizes data that oral #PrEP works for cisgender women when taken 4 or more times per week JAMA Network 👇 bit.ly/3TFz2jl

Tune in Tuesday 👇as we discuss some of the most exciting research coming out of #CROI2024 !

The SEARCH Dynamic Choice study offered oral #PrEP , PEP or injectable cabotegravir to both men and women, and an option to switch products. Join us to learn more, avac.org/event/search-d…